Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion

QR Code

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion

AIM: To observe the therapeutic efficacy of intravitreal injection of conbercept for macular edema in different types of retinal vein occlusion(RVO).METHODS: Retrospective cohort study of 79 patients 79 eyes in different types of RVO(BRVO:54; non-ischemic CRVO: 16; ischemic CRVO: 9)received intravit...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Peng-Yao Lin, Yan Shi, Bo Li, Yi-Meng Ruan, Shan-Shan Hua
Format:	article
Langue:	EN
Publié:	Press of International Journal of Ophthalmology (IJO PRESS) 2021
Sujets:	retinal vein occlusion macular edema conbercept anti-vegf Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/a7e72d91e60b4fc886a730847b5ebc29
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Efficacy of anti-VEGF therapy combined with iontophoresis of Xueshuantong injection on retinal vein obstruction with macular edema
par: Zi-Yue Xiang, et autres
Publié: (2021)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
par: Paulose R, et autres
Publié: (2016)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Vitrectomy for macular edema due to retinal vein occlusion
par: Kumagai K, et autres
Publié: (2019)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
par: Takeyama M, et autres
Publié: (2017)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
par: Andrzej Grzybowski, et autres
Publié: (2021)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
par: Oellers P, et autres
Publié: (2016)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
par: Tsai MJ, et autres
Publié: (2018)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
par: Michalska-Małecka K, et autres
Publié: (2016)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
par: Kawamura M, et autres
Publié: (2018)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
par: Tagami M, et autres
Publié: (2017)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
par: Kumagai K, et autres
Publié: (2019)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Sivaprasad S, et autres
Publié: (2016)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
par: Callizo J, et autres
Publié: (2019)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2017)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
par: Singer MA, et autres
Publié: (2016)

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
par: Nishida A, et autres
Publié: (2017)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
par: Kartasasmita AS, et autres
Publié: (2016)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
par: I. V. Zlobin, et autres
Publié: (2019)

Bilateral retinal hemorrhages and macular edema in a patient with dengue fever associated with cerebral hemorrhage
par: Rajesh Subhash Joshi, et autres
Publié: (2021)

Morphologic Classifications and Locations of Microaneurysms and Clinical Relevance in Branch Retinal Vein Occlusion
par: Esaki Y, et autres
Publié: (2020)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
par: Wallsh J, et autres
Publié: (2020)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
par: Jumper JM, et autres
Publié: (2018)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
par: Karagiannis DA, et autres
Publié: (2020)

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments
par: Shirakata Y, et autres
Publié: (2016)

Central retinal vein occlusion and pseudoexfoliation syndrome
par: Karagiannis D, et autres
Publié: (2015)

Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
par: Qi Zhang, et autres
Publié: (2021)

Dexamethasone implant in retinal vein occlusions
par: Han SB, et autres
Publié: (2016)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
par: Zhuang Cui, et autres
Publié: (2021)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Hall J
Publié: (2016)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
par: Tran THC, et autres
Publié: (2021)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2016)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
par: Narayanan R, et autres
Publié: (2016)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
par: Kim MS, et autres
Publié: (2021)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
par: A. G. Shchuko, et autres
Publié: (2020)

Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study
par: Muto T, et autres
Publié: (2019)

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report
par: Xiuyu Zhu, et autres
Publié: (2021)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
par: Cui C, et autres
Publié: (2017)

Systemic abnormalities associated with retinal vein occlusion in young patients
par: Sinawat S, et autres
Publié: (2017)